Oramed Pharmaceuticals Cash Conversion Cycle 2011-2025 | ORMP

Annual Cash Conversion Cycle Oramed Pharmaceuticals

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-5.42 K	4.82 K	-1.11 K	-1.05 K	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
4.82 K	-5.42 K	-693

Quarterly Cash Conversion Cycle Oramed Pharmaceuticals

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-29.8	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1.29 K	-	-	-2.68 K	1.09 K	-	-3.39 K	-	-663	-663	-	-344	5.36 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
5.36 K	-3.39 K	-289

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Arbutus Biopharma Corporation ABUS	31.5	$ 4.93	4.78 %	$ 818 M	Canada
Aclaris Therapeutics ACRS	-881	$ 3.2	-1.69 %	$ 247 M	USA
Aptevo Therapeutics APVO	-47.4	$ 1.07	-5.75 %	$ 295 K	USA
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	25	-	-15.15 %	$ 60.3 M	Britain
Albireo Pharma ALBO	-1.55 K	-	-0.23 %	$ 916 M	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Ampio Pharmaceuticals AMPE	-2.85 K	-	-11.43 %	$ 502 K	USA
Amphastar Pharmaceuticals AMPH	166	$ 26.45	4.67 %	$ 1.28 B	USA
Anika Therapeutics ANIK	270	$ 9.6	0.37 %	$ 141 M	USA
Catalyst Biosciences CBIO	391	$ 12.98	-7.91 %	$ 854 M	USA
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
Axon Enterprise AXON	86.2	$ 548.58	-2.78 %	$ 41.6 B	USA
Ayala Pharmaceuticals AYLA	-2.15 K	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	174	$ 2.37	2.83 %	$ 14.9 M	USA
AstraZeneca PLC AZN	-58	$ 91.59	1.95 %	$ 96.9 B	Britain
Celldex Therapeutics CLDX	-6.08 K	$ 27.09	-1.53 %	$ 1.74 M	USA
Acorda Therapeutics ACOR	117	-	-24.86 %	$ 820 K	USA
Brickell Biotech BBI	149	-	-5.38 %	$ 6.06 M	USA
BeiGene, Ltd. BGNE	49.5	-	0.49 %	$ 251 B	Cayman-islands
Biohaven Pharmaceutical Holding Company Ltd. BHVN	209	$ 11.33	-1.78 %	$ 733 M	USA
Biogen BIIB	387	$ 175.2	0.63 %	$ 25.5 B	USA
Abeona Therapeutics ABEO	387	$ 5.07	-5.5 %	$ 108 M	USA
Corcept Therapeutics Incorporated CORT	-186	$ 87.67	-0.36 %	$ 9.05 B	USA
ADiTx Therapeutics ADTX	-4.31 K	$ 1.43	-36.18 %	$ 18.8 K	USA
Bellicum Pharmaceuticals BLCM	6.09	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	214	-	-7.31 %	$ 87 M	USA
Advaxis ADXS	-143 K	-	-9.65 %	$ 45.9 M	USA
Catalyst Pharmaceuticals CPRX	54.2	$ 24.29	2.84 %	$ 2.88 B	USA